Investigations of the relationship between infections with Borrelia burgdorferi and glomerulonephritis in Bernese Mountain dogs by Gerber, B
Vetsuisse-Fakultät der Universität Zürich 
 
Klinik für Kleintiermedizin 
 
(Direktorin: Prof. Dr. Claudia Reusch) 
 
 
 
 
Investigations of the relationship between infections with 
Borrelia burgdorferi and glomerulonephritis in Bernese 
Mountain dogs 
(Untersuchungen zum Zusammenhang von Infektionen mit 
Borrelia burgdorferi und Glomerulonephritiden beim Berner 
Sennenhund) 
 
 
 
 
Habilitationsschrift 
Zur Erlangung der Venia Legendi der Vetsuisse-Fakultät der Universität Zürich 
 
 
 
vorgelegt von 
 
Bernhard Gerber 
 
Dr. med. vet. 
Diplomate of the American College of Veterinary Internal Medicine 
Diplomate of the European College of Veterinary Internal Medicine Companian 
Animals 
 
 
 
 
Zürich, 2010 
 
 
 2
 3
 
Content 
 
Chapter 1  Introduction and Goals          5 
 
Chapter 2  Increased prevalence of Borrelia burgdorferi infections in  15 
 Bernese Mountain Dogs: a possible breed predisposition 
 
Chapter 3  Association of urine protein excretion and infection with  25 
  Borrelia burgdorferi sensu lato in Bernese Mountain dogs 
 
Chapter 4 Follow- up of Bernese Mountain dogs and other dogs with  29 
 serologically diagnosed Borrelia burgdorferi infection:  What 
 happens to seropositive animals? 
 
Chapter 5 Complement C3 in Bernese Mountain dogs     39 
 
Chapter 6  Comparison of a rapid immunoassay for antibodies to the C6 47 
 antigen with conventional tests for antibodies against 
 B. burgdorferi in dogs in Europe 
 
Chapter 7 The dilemma with Lyme borreliosis in the dog with particular 53 
 consideration of „Lyme nephritis“ [Das Dilemma der Lyme 
 Borreliose beim Hund unter besonderer Berücksichtigung der 
 „Lyme Nephritis“. In German] 
 
Chapter 8  Summary and Conclusions        61 
 
Chapter 9  Acknowledgments [in German]       67 
 4
 5
 
Chapter 1 Introduction and Goals 
 
Preamble 
 Is there a causal relationship between Lyme disease (borreliosis) and glomerulonephritis 
in Bernese Mountain dogs? The question arose because Bernese Mountain dogs had a high 
incidence of glomerular kidney disease and were often found to be positive in tests for 
antibodies against Borrelia burgdorferi as well (Preiss, 1991; Reusch et al., 1991; Minkus et 
al., 1994; Reusch et al., 1994). 
 
 
Borreliosis in dogs 
 Borrelia are spirochetes with a worldwide distribution. Transmission from one animal 
to another is via ticks of the Ixodes genus. Species belonging to the B. burgdorferi sensu lato 
(henceforth referred to as B. burgdorferi for brevity) complex are the cause of Lyme disease 
or borreliosis, and in humans lead to clinical signs involving the skin, joints, meninges and 
cardiac muscle. These signs are typically preceded by “erythema migrans“, a characteristic 
circular erythematous rash associated with the tick bite. In Europe, the most important species 
belonging to the B. burgdorferi complex are B. garinii, B. afzelii and B. burgdorferi sensu 
stricto. B. burgdorferi sensu stricto is the primary species seen in the USA.  
 Dogs are also susceptible to Lyme borreliosis. Young beagles, experimentally infected 
with B. burgdorferi, had fever, intermittent lameness with swollen joints, lymphadenopathy 
and anorexia (Greene and Straubinger, 2006). However, “erythema migrans“ was not seen. 
Postmortem examination 49 to 581 days post infection revealed enlarged lymph nodes with 
follicular and parafollicular hyperplasia, polyarthritis that was associated with swollen joints 
in some dogs, dermatitis in the region where the tick was attached, and in some dogs, 
periarteritis and perineuritis in the joint capsule, perinodal soft tissues and skin. Lesions were 
not seen in any other organs (Summers et al., 2005). Other signs that have been associated 
with borreliosis in dogs, such as rheumatoid arthritis (Roush et al., 1989), neurological 
dysfunction (Azuma et al., 1993), cardiac arrhythmia (Levy and Duray, 1988) and 
glomerulonephritis (Dambach et al., 1997), could not be reproduced in experimental studies. 
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Bernese Mountain dogs and glomerulonephritis 
 Glomerulonephritis is a renal disease that manifests as protein loss through the urine 
and a decrease in the functional mass of the kidneys (Vaden, 2005). The most important 
sequels are edema, effusion and renal failure. Deposition of immune complexes, which result 
from chronic infection, is the most common cause of glomerulonephritis. 
 In a study at the University of Zurich, it was shown that the incidence of 
glomerulonephritis in Bernese Mountain dogs was 13.9 times higher than in the general dog 
population (Preiss, 1991). An increased incidence of glomerulonephritis in Bernese Mountain 
dogs was seen by numerous clinicians and confirmed in other studies (Reusch et al., 1991; 
Minkus et al., 1994; Reusch et al., 1994). The Bernese Mountain dogs described in those 
studies had membranoproliferative glomerulonephritis with interstitial nephritis, which was 
usually fatal. The dogs at the same time had high antibody titers to B. burgdorferi. This lead 
to the question of a possible causal relationship between B. burgdorferi infection and 
glomerulonephritis in Bernese Mountain dogs. 
 
 
Borreliosis and glomerulonephritis 
 A putative association between Lyme borreliosis and glomerulonephritis was discussed 
as early as 1987 (Magnarelli et al., 1987). Five dogs with antibodies to B. burgdorferi 
developed renal disease during or after episodes of intermittent lameness. The renal disease 
was not characterized further but was associated with proteinuria and hypoalbuminaemia in 
some of the dogs. Spirochete bacteria identified as B. burgdorferi were detected in the kidney 
tissue of one dog. In a report one year later, glomerular lesions were described in a Labrador 
Retriever with a high antibody titer to B. burgdorferi (Grauer et al., 1988); Borrelia were 
identified in the renal interstitium using immunofluorescence. In the 1990s, two studies of 49 
dogs with antibody titers to B. burgdorferi and specific renal lesions (Dambach et al., 1992; 
Dambach et al., 1997) were published. Most of the lesions were membranoproliferative 
glomerulonephritis, diffuse cortical tubular dilatation with tubular necrosis and tubular 
regeneration as well as diffuse interstitial, lymphoplasmacytic inflammation. The term „Lyme 
nephritis“ was coined, although a direct relationship between Lyme borreliosis and 
glomerulonephritis had not been established (Littman et al., 2006). 
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Complement C3 glomerulonephritis and B. burgdorferi infection 
 The complement system is an important part of innate immunity and together with 
acquired immunity provides defence against infection, including infection with B. burgdorferi 
(Aberer, 2007). Activated complement and specific antibodies are responsible for 
opsonisation and lysis of bacteria. Some species of B. burgdorferi are able to evade 
complement-facilitated elimination, possibly through binding of complement-inhibiting 
factors such as factors H and FHL-1 (factor H-like protein 1), which inhibit the production of 
complement C3b and enhance its inactivation (Alitalo et al., 2001). Infection can be 
established by bacteria that evade the complement system. B. afzelii has been shown to bind 
complement-inhibiting factors, whereas B. garinii has been considered very sensitive to 
complement-facilitated elimination. B. garinii is the most common species of Borrlia in 
Switzerland (Jouda et al., 2003). A deficiency in complement could theoretically result in a 
marked increase in infection with B. garinii because of a lack of complement-facilitated 
elimination. 
 Complement C3 is the most important component of the complement system (Tizard, 
2004). Dogs with a genetic deficiency of complement C3 have a high incidence of renal 
disease with glomerulonephritis (Blum et al., 1985). Of 20 affected dogs, five had clinical 
signs of membranoproliferative glomerulonephritis and 14 of the remaining 15 had 
histological renal lesions consistent with membranoproliferative glomerulonephritis (Cork et 
al., 1991). Complement has been shown to play an important role in immune complex-
mediated renal disease (Berger and Daha, 2007). In a study of children with type II 
membranoproliferative glomerulonephritis, there was a decreased level of complement C3 in 
most of the patients (Schwertz et al., 2001). In 88% of the children, antibodies to complement 
C3 convertase, the so-called C3-nephritic factor, were found. This factor leads to extension of 
the half-life of complement C3 convertase and thus, to a deficiency of complement C3. 
Therefore, a deficiency of complement C3 can be initially involved with glomerulonephritis 
as well as with B. burgdorferi infection. 
 
 
Diagnosis of Lyme borreliosis 
 „Erythema migrans“ is the hallmark of Lyme borreliosis in humans (Stanek and Strle, 
2003). However, because this sign does not occur in dogs, clinical manifestation of the 
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disease is much less clear (Littman et al., 2006). To complicate matters, there are no 
standardised tests in dogs (Jacobson et al., 1996). Diagnosis of B. burgdorferi infection is 
usually based on detection of antibodies using a combination of ELISA or indirect 
immunfluorescence and Western blot (Littman et al., 2006). However, different tests and 
interpretations of the tests are responsible for considerable variations of the results. Culture 
and polymerase chain reaction (PCR) are other ways of identifying B. burgdorferi, but those 
two methods have disadvantages in comparison with serological methods. Culture depends on 
specialised laboratories, is very labour intensive and often unproductive (Stanek and Strle, 
2003). Polymerase chain reaction is easier to conduct but the specificity of identifying an 
active infection is considered low because the test does not differentiate between living and 
dead organisms (Hengge et al., 2003). False positive results are common when ELISA is used 
because of the similarity of antigens of B. burgdorferi to those of other spirochetes and other 
bacteria that may occur as commensals or pathogens in dogs.  
 In newer test methods, the specificity of ELISA has been increased by using the 
recombinant peptide C6 as the antigen. This peptide corresponds to IR6, an immunodominant 
region of the VlsE (Vmp-like sequence, Expressed) superficial lipoprotein of B. burgdorferi, 
and is genetically, structurally and antigenically conserved across various species of B. 
burgdorferi (Greene and Straubinger, 2006). It was first isolated from a European strain of B. 
garinii. The genes of IR6 are only expressed during replication in mammalian hosts. The 
peptide does not occur in ticks that have not had a blood meal, and therefore serves as a 
marker of active infection. The use of this peptide in serological tests is progressively 
replacing older methods. In the USA, tests based on the C6 peptide are considered to be 
highly specific (99%) for the diagnosis of borreliosis in humans. The sensitivity varied from 
62% to 100% depending on the stage of the disease (Liang et al., 1999). A C6 ELISA proved 
to be reliable in detecting borreliosis in humans with clearly-defined clinical signs of Lyme 
disease in Europe (Liang et al., 2000a) although it was earlier found that European patients 
had a lower antibody response to infection with B. burgdorferi (Dressler et al., 1994; Hauser 
et al., 1997). 
 ELISA tests based on the C6 peptide have also been used in dogs. In an American 
study, a C6 ELISA produced the same results as a whole-cell ELISA combined with Western 
blot (Levy et al., 2002). In experimentally-infected dogs, the antibody titer to C6 increased 
after infection more rapidly than titers measured with other methods, and decreased after 
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treatment faster than the antibody titers measured with other methods (Liang et al., 2000b; 
Straubinger et al.; Philipp et al., 2001). Compared with other tests, the C6 ELISA test does 
not cross react with dirofilaria, babesia, ehrlichia or leptospira and does not produce positive 
results in dogs that have been immunized against B. burgdorferi (Liang et al., 2000b; 
O'Connor et al., 2004). The C6 ELISA test has been used in dogs in Europe (Krupka et al., 
2007), but has not been compared with conventional tests. In the USA, B. burgdorferi sensu 
stricto is the only species of Borrelia that causes Lyme borreliosis, whereas in Europe, the 
disease is usually the result of infection with B. afzelii or B. garinii (Steere, 2001). Therefore, 
although the C6 ELISA is reliable for the diagnosis of borreliosis in dogs in the USA, the 
same could not automatically be assumed for dogs in Europe. 
 
 
Problems and Goals 
 Based on information that was available, it was not clear whether there is an association 
between infection with B. burgdorferi and glomerulonephritis in Bernese Mountain dogs, or if 
the two occurrences are merely coincidental. To investigate this problem, the prevalence of 
antibodies to B. burgdorferi in Bernese Mountain dogs was first determined. Subsequently, 
Bernese Mountain dogs seropositive for B. burgdorferi were examined for an increase in 
proteinuria as a marker of glomerular disease and were monitored for signs of 
glomerulonephritis later in life. 
 Furthermore, because it was not known whether a deficiency in complement C3 is 
associated with B. burgdorferi infection and glomerulonephritis in Bernese Mountain dogs, 
the concentration of complement C3 was determined in B. burgdorferi-seropositive and 
seronegative Bernese Mountain dogs, and the results were compared with those of dogs of 
other breeds. 
 The reliability of the C6-ELISA test for diagnosis of Lyme borreliosis in dogs in Europe 
was investigated by comparing the results with those of the recommended combination of a 
conventional whole-cell ELISA with a Western blot. 
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Chapter 8  Summary and Conclusions 
 
This study provided some interesting answers to questions raised in the introduction: 
 
What is the seroprevalence of B. burgdorferi in Bernese Mountain dogs? 
 Fifty-eight per cent of healthy Bernese Mountain dogs had antibodies against B. 
burgdorferi (Chapter 2). The control dogs, which consisted of large long-haired dogs of other 
breeds, had a prevalence of 15%. The reasons for this difference are obscure. The Bernese 
Mountain dogs and control dogs lived under comparable conditions and thus, a difference in 
exposure to infected ticks was ruled out as a possible reason. One could speculate that the 
dark coat of the Bernese Mountain dog hampers detection and removal of ticks by owners, 
and thus promotes the transmission of B. burgdorferi to dogs of this breed, but a dark coat 
was not a risk factor for borreliosis in control dogs. The subpopulation of control dogs with a 
dark coat had a significantly lower seroprevalence of B. burgdorferi than Bernese Mountain 
dogs (28% versus 58%, P=0.011). 
 Vaccination against B. burgdorferi was also ruled out as a possible reason for the 
difference between the two groups; of the four vaccinated Bernese Mountain dogs, one was 
seronegative and three were seropositive for B. burgdorferi, and of the six vaccinated control 
dogs, three were seropositive and three were seronegative. 
 Cross-reaction with other bacteria may potentially interfere with serological tests. To 
minimize this risk, all tested serum samples were absorbed using a mixture of formalin-
inactivated bacteria before the ELISA was carried out. In addition, all serum samples were 
subjected to a micro-agglutination test for leptospira antibodies. Fifty-four per cent of dogs 
had antibodies to leptospira, but these had no apparent effect on the seroprevalence of B. 
burgdorferi; there was no difference between dogs that were seropositive and seronegative for 
B. burgdorferi with respect to the occurrence of leptospira antibodies. 
 Because we were unable to identify a cause for the high seroprevalence of B. 
burgdorferi in Bernese Mountain dogs, we wondered whether there was a breed disposition; 
however, a breed disposition to increased antibody titres against infectious agents has not 
been reported in dogs. 
 The consequence of the high seroprevalence of B. burgdorferi is, that it is difficult to 
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establish a causal relationship between infection with B. burgdorferi and clinical disease, 
because of the likelihood that the two occurrences are coincidental. 
 
 
Is the seroprevalence of B. burgdorferi associated with an increase in urinary protein 
excretion, which in turn could be used as a marker of glomerular disease in Bernese Mountain 
dogs? 
 Urinary protein concentrations in healthy but B. burgdorferi-seropositive Bernese 
Mountain dogs did not differ from those in seronegative Bernese Mountain dogs or from 
those in control dogs (Chapter 3). To detect very small urinary protein concentrations and to 
identify urinary protein patterns, a sensitive immunoassay for urinary albumin and a sodium 
dodecyl sulphate-agarose gel electrophoresis were employed, in addition to conventional 
laboratory methods, such as urine test strips and measurement of the urine protein-to-
creatinine ratio. These sensitive methods failed to detect any changes in urinary protein 
excretion in B. burgdorferi-seropositive Bernese Mountain dogs. Similarly, a study involving 
young healthy Golden retrievers did not find an association between seroprevalence of B. 
burgdorferi and microalbuminuria (Goldstein et al., 2007). 
 
 
Are B. burgdorferi-seropositive Bernese Mountain dogs predisposed to clinical signs 
characteristic of glomerulonephritis later in life? 
 There was no information about the long-term effects of B. burgdorferi infection in 
adult dogs so far. Of 83 dogs, (33 were B. burgdorferi-seropositive and 50 seronegative at the 
initial examination), 57 maintained their serological status, 11 seroconverted and 12 
seroreverted after a period of 2.5 to 3 years, when they were examined a second time (Chapter 
4). There was no difference between Bernese Mountain dogs and control dogs with respect to 
change of serological status. Eight owners (3 of Bernese Mountain dogs and 5 of control 
dogs) felt that the general health of their dog was abnormal at the second examination. 
Although these were very non-specific assessments, the findings could reflect subclinical 
disease; similar non-specific signs have also been associated with ‘chronic’ Lyme disease in 
humans (Feder et al., 2007). However, a relationship between abnormal general condition and 
demeanour and a titre to B. burgdorferi could not be confirmed. On the other hand, there was 
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an association between age and abnormal general condition; dogs with a normal general 
condition were younger than dogs with an abnormal general condition (median, 6 versus 10 
years). Furthermore, there was no association between lameness, which is the classical sign of 
experimental Lyme disease, and the occurrence of antibodies to B. burgdorferi. As well, there 
was no difference between the prevalence of lameness at the first and second examinations 
neither in the seropositive dogs nor in the seronegative dogs. This confirms the findings of a 
previous study where the authors postulated that the serological status of healthy dogs with 
respect to B. burgdorferi does not allow one to predict the likelihood of future lameness of the 
animal (Levy and Magnarelli, 1992).  
 The serum concentrations of urea and creatinine, two important indicators of renal 
insufficiency, did not increase between the first and second examinations in both groups. On 
the other hand, the proportion of Bernese Mountain dogs with proteinuria, as measured with 
test strips, did increase, but the increase occurred in both seropositive and seronegative dogs. 
 In summary, there was no difference in the health status of dogs 2.5 to 3 years after they 
were examined serologically and found to be either seronegative or seropositive for B. 
burgdorferi.  
 
 
Do Bernese Mountain dogs have lower complement C3 concentrations compared with dogs of 
other breeds? 
 The reason we measured complement C3 in serum of Bernese Mountain dogs and 
compared the concentrations with those of dogs of other breeds was because infection, as well 
as glomerulonephritis, have been associated with lowered complement C3 concentrations 
(Chapter 5). However, this study showed that in Bernese Mountain dogs, complement C3 
concentrations were not decreased; in fact, for unknown reasons, complement C3 
concentrations were higher than in dogs of other breeds. Therefore, there was no breed-
associated decrease in complement C3 that could explain the simultaneous occurrence of B. 
burgdorferi antibodies and glomerulonephritis in Bernese Mountain dogs. Regarding the 
higher level of C3 it was speculated that in Bernese Mountain dogs a breed which is 
susceptible to histiocytic sarcomas, very active dendritic cells might contribute to the 
increased serum level of complement C3. Histiocytic sarcomas likely arise from dendritic 
cells and it is known that dendritic cells produce complement C3 in humans and mice. 
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Are test methods based on recombinant peptide C6 adequate for the detection of antibodies 
against B. burgdorferi in dogs in Europe? 
 A conventional test method (whole-cell ELISA combined with Western blot) was 
compared with a rapid test based on recombinant peptide C6 (Chapter 6). The C6 test method 
had only been evaluated in dogs in the USA, and therefore, it could not automatically be 
assumed that it also worked in Europe, where different B. burgdorferi species predominate. 
However, we showed that this test produces reliable results under European conditions, 
although the agreement with conventional test methods was not as good as in American 
studies. Using conventional methods as the gold standard, the C6 test method carried out in 
our clinic had a sensitivity of 0.81 and a specificity of 0.77, compared with sensitivities of 
0.75 to 1.00 and specificities of 0.94 to 1.00 in American studies (Liang et al., 2000; Levy, 
2002; Goldstein et al., 2007). Interestingly, we found that the agreement between 
conventional tests and the C6 rapid test depended on the breed of dogs tested; whereas in the 
Bernese Mountain dogs sensitivity was 0.96 and specificity 0.66 in control dogs sensitivity 
was 0.39 and specificity 0.92 (Kappa= 0.681; P<0.001 in Bernese Mountain dogs and 0.347; 
P=0.01 in control dogs). We were unable to explain this difference.  
 
 
Conclusions 
 The present study did not reveal an association between seroprevalence of B. 
burgdorferi and clinical signs of glomerular disease in Bernese Mountain dogs. Therefore we 
doubt that an association between B. burgdorferi infection and glomerulonephritis exists 
(Chapter 7). The high seroprevalence of B. burgdorferi in the Bernese Mountain dog 
population suggests that the simultaneous occurrence of glomerulonephritis and borreliosis is 
coincidental and does not have a causal component. 
 The commonly encountered simultaneous occurrence of glomerulonephritis and 
seroprevalence of B. burgdorferi in Bernese Mountain dogs is not associated with a decreased 
complement C3 concentration. 
 A rapid test that is based on recombinant peptide C6 is useful for the detection of B. 
burgdorferi antibodies in dogs in Europe. 
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